Cardiac events after using clarithromycin for anti-Helicobacter pylori therapy in patients with coronary artery disease

Clarithromycin is an antibiotic commonly used to treat Helicobacter pylori infections. The US Food and Drug Administration (FDA) advises caution before prescribing clarithromycin to patients with cardiac diseases. This study aimed to evaluate cardiac events after anti-H pylori treatment in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Cheng-Kuan, Lee, Tzong-Hsi, Liao, Pen-Chih, Lin, Cheng-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637519/
https://www.ncbi.nlm.nih.gov/pubmed/37960819
http://dx.doi.org/10.1097/MD.0000000000035922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637519/
https://www.ncbi.nlm.nih.gov/pubmed/37960819
http://dx.doi.org/10.1097/MD.0000000000035922

Ejemplares similares